These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 16687136)

  • 1. Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by delta9-tetrahydrocannabinol.
    Williams IJ; Edwards S; Rubo A; Haller VL; Stevens DL; Welch SP
    Eur J Pharmacol; 2006 Jun; 539(1-2):57-63. PubMed ID: 16687136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL; Martin ZL; Smith FL; Welch SP
    J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
    Williams J; Haller VL; Stevens DL; Welch SP
    Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat.
    Cox ML; Haller VL; Welch SP
    Eur J Pharmacol; 2007 Jul; 567(1-2):125-30. PubMed ID: 17498686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal delta9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP; Smith FL
    Eur J Pharmacol; 2005 Nov; 525(1-3):74-82. PubMed ID: 16288738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration.
    Cichewicz DL; McCarthy EA
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1010-5. PubMed ID: 12604676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
    Frederickson RC; Hewes CR; Aiken JW
    J Pharmacol Exp Ther; 1976 Nov; 199(2):375-84. PubMed ID: 988178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.
    Cadoni C; Pisanu A; Solinas M; Acquas E; Di Chiara G
    Psychopharmacology (Berl); 2001 Nov; 158(3):259-66. PubMed ID: 11713615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.
    Pugh G; Smith PB; Dombrowski DS; Welch SP
    J Pharmacol Exp Ther; 1996 Nov; 279(2):608-16. PubMed ID: 8930163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
    Jardinaud F; Roques BP; Noble F
    Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propofol sedation is reduced by delta9-tetrahydrocannabinol in mice.
    Brand PA; Paris A; Bein B; Meybohm P; Scholz J; Ohnesorge H; Tonner PH
    Anesth Analg; 2008 Jul; 107(1):102-6. PubMed ID: 18635473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine.
    Cheng HY; Laviolette SR; van der Kooy D; Penninger JM
    Eur J Neurosci; 2004 Jun; 19(11):3033-41. PubMed ID: 15182311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol.
    Smith FL; Cichewicz D; Martin ZL; Welch SP
    Pharmacol Biochem Behav; 1998 Jun; 60(2):559-66. PubMed ID: 9632241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of delta9-tetrahydrocannabinol on the conversion of [3H]trypotphan to 5-[3H] hydroxytryptamine in the mouse brain.
    Johnson KM; Dewey WL
    J Pharmacol Exp Ther; 1978 Oct; 207(1):140-50. PubMed ID: 702335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profound hypothermia in mammals treated with tetrahydrocannabinols, morphine, or chlorpromazine.
    Haavik CO
    Fed Proc; 1977 Nov; 36(12):2595-8. PubMed ID: 913617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine.
    Roberts JD; Gennings C; Shih M
    Eur J Pharmacol; 2006 Jan; 530(1-2):54-8. PubMed ID: 16375890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ephedrine and phenylpropanolamine on the antinociceptive effects of morphine and codeine in mice.
    Dambisya YM; Wong CL; Chan K
    Arch Int Pharmacodyn Ther; 1990; 308():5-12. PubMed ID: 2099137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription.
    Khare M; Taylor AH; Konje JC; Bell SC
    Mol Hum Reprod; 2006 May; 12(5):321-33. PubMed ID: 16597638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing the selectivity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol: complete substitution with methanandamide.
    Alici T; Appel JB
    Pharmacol Biochem Behav; 2004 Nov; 79(3):431-7. PubMed ID: 15582014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.